Skip to main content

Tehrani Ali's Form 4 filing

Zymeworks Inc. (ZYME) · filed Jul 13, 2021

Accession no.
0000899243-21-028253
Filed
Jul 13, 2021
Trade date
Jul 12, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $457.6K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Tehrani AliCIK 0001761853Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 12, 2021Common SharesMOption exerciseAcquired+12,669$4.31F2+$54,603.39272,994Direct
Jul 12, 2021Common SharesSSaleDisposed−12,669$36.12F3−$457,604.28260,325Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 12, 2021Common SharesMOption exerciseDisposed−12,669$0.00$044,991Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The exercise price of the stock option is CAD5.37. The U.S. dollar equivalent of the exercise price is $4.3062 using the Bank of Canada exchange rate for July 12, 2021 (CAD1.00 = $0.8019).

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.0649 to $36.5902, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 12, 2021 at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)